• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自体激活雪旺细胞移植治疗脊髓损伤:6 例,5 年以上随访。

Transplantation of autologous activated Schwann cells in the treatment of spinal cord injury: six cases, more than five years of follow-up.

机构信息

Department of Orthopaedics, Tianjin Medical University General Hospital, Tianjin, P.R. China.

出版信息

Cell Transplant. 2012;21 Suppl 1:S39-47. doi: 10.3727/096368912X633752.

DOI:10.3727/096368912X633752
PMID:22507679
Abstract

Schwann cells (SCs) are the main glial cells of the peripheral nervous system, which can promote neural regeneration. Grafting of autologous SCs is one of the well-established and commonly performed procedures for peripheral nerve repair. With the aim to improve the clinical condition of patients with spinal cord injury (SCI), a program of grafting autologous activated Schwann cells (AASCs), as well as a series of appropriate neurorehabilitation programs, was employed to achieve the best therapeutic effects. We selected six patients who had a history of SCI before transplantation. At first, AASCs were obtained by prior ligation of sural nerve and subsequently isolated, cultured, and purified in vitro. Then the patients accepted an operation of laminectomy and cell transplantation, and no severe adverse event was observed in any of these patients. Motor and sensitive improvements were evaluated by means of American Spinal Injury Association (ASIA) grading and Functional Independence Measure (FIM); bladder and urethral function were determined by clinical and urodynamic examination; somatosensory evoked potentials (SSEPs) and motor evoked potentials (MEPs) were used to further confirm the functional recovery following transplantation. The patients were followed up for more than 5 years. All of the patients showed some signs of improvement in autonomic, motor, and sensory function. So we concluded that AASC transplantation might be feasible, safe, and effective to promote neurorestoration of SCI patients.

摘要

许旺细胞(SCs)是周围神经系统的主要神经胶质细胞,能够促进神经再生。自体许旺细胞移植是周围神经修复的成熟且常用的方法之一。为了改善脊髓损伤(SCI)患者的临床状况,我们采用了自体激活许旺细胞(AASCs)移植方案以及一系列适当的神经康复方案,以达到最佳的治疗效果。我们选择了六位在移植前有 SCI 病史的患者。首先,通过结扎腓肠神经获得 AASCs,然后在体外进行分离、培养和纯化。随后,患者接受了椎板切除术和细胞移植手术,这些患者均未观察到任何严重的不良事件。通过美国脊髓损伤协会(ASIA)分级和功能独立性测量(FIM)评估运动和感觉改善情况;通过临床和尿动力学检查确定膀胱和尿道功能;通过体感诱发电位(SSEP)和运动诱发电位(MEP)进一步确认移植后的功能恢复情况。这些患者的随访时间超过 5 年。所有患者的自主、运动和感觉功能都有一定程度的改善。因此,我们得出结论,AASC 移植可能是一种可行、安全且有效的方法,能够促进 SCI 患者的神经修复。

相似文献

1
Transplantation of autologous activated Schwann cells in the treatment of spinal cord injury: six cases, more than five years of follow-up.自体激活雪旺细胞移植治疗脊髓损伤:6 例,5 年以上随访。
Cell Transplant. 2012;21 Suppl 1:S39-47. doi: 10.3727/096368912X633752.
2
Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes.自体雪旺细胞移植治疗慢性胸段脊髓损伤患者:关于安全性考量及可能结果的中期报告
Neurosci Lett. 2008 Sep 26;443(1):46-50. doi: 10.1016/j.neulet.2008.07.041. Epub 2008 Jul 22.
3
Autologous olfactory ensheathing cell transplantation in human spinal cord injury.自体嗅鞘细胞移植治疗人类脊髓损伤
Brain. 2005 Dec;128(Pt 12):2951-60. doi: 10.1093/brain/awh657. Epub 2005 Oct 11.
4
Acute transplantation of olfactory ensheathing cells or Schwann cells promotes recovery after spinal cord injury in the rat.急性移植嗅鞘细胞或雪旺细胞可促进大鼠脊髓损伤后的恢复。
J Neurosci Res. 2004 Mar 1;75(5):632-41. doi: 10.1002/jnr.20029.
5
Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury.嗅鞘细胞移植治疗完全性慢性脊髓损伤患者的长期疗效。
Cell Transplant. 2012;21 Suppl 1:S23-31. doi: 10.3727/096368912X633734.
6
Safety and possible outcome assessment of autologous Schwann cell and bone marrow mesenchymal stromal cell co-transplantation for treatment of patients with chronic spinal cord injury.自体雪旺细胞和骨髓间充质基质细胞联合移植治疗慢性脊髓损伤患者的安全性和可能结局评估。
Cytotherapy. 2013 Jul;15(7):782-91. doi: 10.1016/j.jcyt.2013.03.012.
7
BD PuraMatrix peptide hydrogel as a culture system for human fetal Schwann cells in spinal cord regeneration.BD PuraMatrix 肽水凝胶作为脊髓再生中人胎儿雪旺细胞的培养系统。
J Neurosci Res. 2012 Dec;90(12):2335-48. doi: 10.1002/jnr.23120. Epub 2012 Sep 20.
8
Schwann cells engineered to express the cell adhesion molecule L1 accelerate myelination and motor recovery after spinal cord injury.经基因工程改造后表达细胞黏附分子 L1 的许旺细胞可加速脊髓损伤后的髓鞘形成和运动功能恢复。
Exp Neurol. 2010 Jan;221(1):206-16. doi: 10.1016/j.expneurol.2009.10.024. Epub 2009 Nov 10.
9
Cograft of neural stem cells and schwann cells overexpressing TrkC and neurotrophin-3 respectively after rat spinal cord transection.分别过表达 TrkC 和神经营养因子-3 的神经干细胞与许旺细胞的组织工程脊髓桥接移植。
Biomaterials. 2011 Oct;32(30):7454-68. doi: 10.1016/j.biomaterials.2011.06.036. Epub 2011 Jul 23.
10
Transplantation of preconditioned Schwann cells following hemisection spinal cord injury.脊髓半切损伤后预处理雪旺细胞的移植。
Spine (Phila Pa 1976). 2007 Apr 20;32(9):943-9. doi: 10.1097/01.brs.0000261408.61303.77.

引用本文的文献

1
Engineered Healing: Synergistic Use of Schwann Cells and Biomaterials for Spinal Cord Regeneration.工程化修复:雪旺细胞与生物材料在脊髓再生中的协同应用
Int J Mol Sci. 2025 Aug 16;26(16):7922. doi: 10.3390/ijms26167922.
2
Schwann Cells and Their Exosomes: Research Progress and Prospect in Spinal Cord Injury.施万细胞及其外泌体:脊髓损伤的研究进展与展望
Neural Plast. 2025 Jun 12;2025:6684089. doi: 10.1155/np/6684089. eCollection 2025.
3
Schwann cells in regeneration and cancer.再生与癌症中的施万细胞。
Front Pharmacol. 2025 Jan 29;16:1506552. doi: 10.3389/fphar.2025.1506552. eCollection 2025.
4
Neurotrauma-From Injury to Repair: Clinical Perspectives, Cellular Mechanisms and Promoting Regeneration of the Injured Brain and Spinal Cord.神经创伤——从损伤到修复:临床视角、细胞机制与促进损伤脑和脊髓的再生
Biomedicines. 2024 Mar 13;12(3):643. doi: 10.3390/biomedicines12030643.
5
The role of apoptosis in spinal cord injury: a bibliometric analysis from 1994 to 2023.细胞凋亡在脊髓损伤中的作用:1994年至2023年的文献计量分析
Front Cell Neurosci. 2024 Jan 16;17:1334092. doi: 10.3389/fncel.2023.1334092. eCollection 2023.
6
CREB1 Facilitates GABAergic Neural Differentiation of Human Mesenchymal Stem Cells through BRN2 for Pain Alleviation and Locomotion Recovery after Spinal Cord Injury.CREB1 通过 BRN2 促进人骨髓间充质干细胞的 GABA 能神经分化,用于缓解脊髓损伤后的疼痛和运动功能恢复。
Cells. 2023 Dec 28;13(1):67. doi: 10.3390/cells13010067.
7
Schwann Cell-Derived Exosomal Vesicles: A Promising Therapy for the Injured Spinal Cord.许旺细胞衍生的外泌体囊泡:一种有前途的脊髓损伤治疗方法。
Int J Mol Sci. 2023 Dec 10;24(24):17317. doi: 10.3390/ijms242417317.
8
Use of Cells, Supplements, and Peptides as Therapeutic Strategies for Modulating Inflammation after Spinal Cord Injury: An Update.细胞、补充剂和肽在脊髓损伤后炎症调节中的治疗策略应用:更新。
Int J Mol Sci. 2023 Sep 11;24(18):13946. doi: 10.3390/ijms241813946.
9
Spinal cord injury: molecular mechanisms and therapeutic interventions.脊髓损伤:分子机制与治疗干预。
Signal Transduct Target Ther. 2023 Jun 26;8(1):245. doi: 10.1038/s41392-023-01477-6.
10
Unleashing Spinal Cord Repair: The Role of cAMP-Specific PDE Inhibition in Attenuating Neuroinflammation and Boosting Regeneration after Traumatic Spinal Cord Injury.释放脊髓修复:cAMP 特异性 PDE 抑制在减轻创伤性脊髓损伤后神经炎症和促进再生中的作用。
Int J Mol Sci. 2023 May 2;24(9):8135. doi: 10.3390/ijms24098135.